Clinical efficacy of HA and CAG regimen on elderly patients with acute non-lymphocytic leukemia

Objective:To compare the clinical effects of harringtonine+arabinosylcytosin (HA) and aclarubicin+arabinosylcytosin+recombinant human granulocyte-colony stimulating factor (CAG) regimen in treatment of acute non-lymphocytic leukemia (ANLL) in the elderly.Methods:Thirty-two elderly patients with ANLL were randomly divided into HA group and CAG group,and the clinical efficacy was compared between the two groups.Results:The complete remission rate was 56.3% in the CAG group and 43.8% in the HA group.The total efficacy rates were 68.8% and 62.5%,respectively.The difference was not significant (P>0.05).Conclusions:CAG regimen is more suitable than HA regimen in treatment of ANLL in the elderly.It is worth popularizing.